Clear Trial Podcast
Proven Methods for Reducing Change Orders and Assessing Their Impact
Join Lisa Henderson, Editor in Chief of Applied Clinical Trials, and Mindy Davis, Director, Clinical Services at ClearTrial, as they discuss how forward-thinking biopharmaceutical and medical device companies are reducing change orders during clinical trials – and how they are managing change orders more effectively when they do occur.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
